跳至主要内容
临床试验/NCT00540787
NCT00540787已完成4 期

A Randomized Comparison of the Efficacy of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation for the Maintenance of Sinus Rhythm In Patients With Paroxysmal Atrial Fibrillation

Biosense Webster, Inc.6 个研究点 分布在 3 个国家目标入组 112 人开始时间: 2003年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
112
试验地点
6
主要终点
Recurrence of Atrial Fibrillation

研究概览

简要总结

The purpose of this study is to compare radiofrequency catheter ablation and antiarrhythmic drug treatment for the maintenance of sinus rhythm in paroxysmal atrial fibrillation patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or older
  • Paroxysmal atrial fibrillation for at least 6 months with at least 2 symptomatic episodes (patient history) during the previous month
  • Atrial fibrillation (patient history or echocardiogram documented) resistant to at least one antiarrhythmic drug of Class I or III
  • Documentation of at least one episode of atrial fibrillation on 12-lead echocardiogram or Holter Monitor

排除标准

  • Contraindications to more than 2 antiarrhythmic drugs of different classes, or to oral anticoagulants
  • History of any previous ablation for atrial fibrillation
  • Intracardiac thrombus
  • Atrial fibrillation due to reversible cause
  • Pregnancy
  • Contraindication to stopping oral anticoagulation (for example as a result of a mechanical cardiac valve)

研究组 & 干预措施

Drug Treatment

Active Comparator

干预措施: Radiofrequency ablation, antiarrhythmic drugs (Device)

Drug Treatment

Active Comparator

干预措施: Amiodarone, flecainide, propafenone, quinidine, dofetilide, sotalol, cibenzoline, beta blocking and calcium channel blocking agents and antiarrhythmic drugs (Drug)

ThermoCool Radiofrequency Catheter

Active Comparator

Radiofrequency catheter used.

干预措施: Radiofrequency ablation, antiarrhythmic drugs (Device)

ThermoCool Radiofrequency Catheter

Active Comparator

Radiofrequency catheter used.

干预措施: ThermoCool Radiofrequency Catheter (Device)

结局指标

主要结局

Recurrence of Atrial Fibrillation

时间窗: One year

To compare the incidence of recurrence of Atrial Fibrillation in the two groups over a follow-up period of one year.

次要结局

  • Efficacy of ablation and drug treatment(One year)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

A Comparison of Antiarrhythmic Drug Therapy and... | 临床试验